in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended to
identify forward-looking statements. Examples of these forward-looking
statements include statements as to the anticipated demand for home and/or
daily hemodialysis products, the anticipated market acceptance and demand
for NxStage's products, including those products recently acquired through
the Medisystems acquisition, anticipated increases in the availability of,
and market and patient awareness regarding, home hemodialysis, anticipated
benefits of the Medisystems acquisition, anticipated reductions in cost of
goods sold, anticipated margin improvements, anticipated patient and center
numbers, anticipated revenues, loss and Adjusted EBITDA, and expectations
as to future operating results. All forward-looking statements involve
risks, uncertainties and contingencies, many of which are beyond NxStage's
control, which may cause actual results, performance, or achievements to
differ materially from anticipated results, performance or achievements,
including market acceptance and demand for NxStage's products, growth in
home and/or daily hemodialysis, unanticipated difficulties in achieving
operational efficiencies and cost reductions, changes in reimbursement for
home and daily hemodialysis, changes in the Company's historical chronic
patient drop and retention rates, changes in the regulatory environment,
and certain other factors that may affect future operating results and
which are detailed in NxStage's filings with the Securities and Exchange
Commission, including the Annual Report on Form 10-K for the year ended
December 31, 2007.
In addition, the statements in this press release represent NxStage's
expectations and beliefs as of the date of this press release. NxStage
anticipates that subsequent events and developments may cause these
expectations and belief
'/>"/>
SOURCE NxStage Medical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related medicine news :1.
NxStage Medical Completes Acquisition of Medisystems2.
NxStage Medical Reports Third Quarter 2007 Results3.
NxStage Medical Establishes $50 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital4.
NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th5.
NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 20086.
NxStage Medical Reports Fourth Quarter and Full Year 2007 Results7.
Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor8.
Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc.9.
NxStage Announces Supply Agreement With Kawasumi Laboratories for Blood Tubing Sets10.
MSU engineering team designs innovative medical device11.
ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference